Case report of tracheobronchial squamous cell carcinoma treated with radiation therapy and concurrent chemotherapy
MetadataShow full item record
CitationAgrawal, Vishesh, J. Paul Marcoux, Michael S. Rabin, Inna Vernovsky, Jon O. Wee, and Raymond H. Mak. 2016. “Case Report of Tracheobronchial Squamous Cell Carcinoma Treated with Radiation Therapy and Concurrent Chemotherapy.” Advances in Radiation Oncology 1 (2) (April): 127–131. doi:10.1016/j.adro.2016.03.003.
AbstractTracheobronchial tumors include primary malignant tumors, secondary malignant tumors, and benign tumors. Primary malignant tumors of the trachea are rare, representing only 0.1% to 0.4% of all malignant disease. Squamous cell carcinoma (SCC) and adenoid cystic carcinoma are the most common histological subtypes, making up approximately two-thirds of primary tracheal neoplasms.1 Such tumors have typically been treated with surgical resection and adjuvant radiation therapy (RT; Table 1). Medically inoperable tumors are usually treated with definitive RT, but because of the rarity of these tumors, there are no randomized trials to determine the optimal treatment regimen. A radiation dose of ∼60 Gy has been most commonly reported for external beam RT, with higher doses having significant toxicity of the tracheal and esophageal tissue using historical techniques. In contrast to definitive RT, the use of definitive RT with concurrent chemotherapy for tracheal SCC has been sparingly described in the literature. In this report, we describe our experience with 2 patients at our institution who received definitive RT using modern techniques with concurrent chemotherapy for tracheobronchial SCC.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:29400427
- HMS Scholarly Articles